- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
GSK
VIR Stock: Why Vir Biotechnology Is Plunging Today
VIR stock is plunging on some pretty unfavorable news about a trial being suspended for the company's prospective Covid-19 vaccine.
GlaxoSmithKline and Sanofi Stock Rally on EU Vaccine Deal
GlaxoSmithKline and Sanofi stock are rallying in early trading on Friday thanks to news they would supply the EU 300 million vaccine doses.
3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline
Friday's big stock charts feature pharmaceutical-market names that recently posted terrific earnings data.
Amarin Has the Makings for a Gamechanging Product
Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.